BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 11687466)

  • 1. Enzyme-linked immunosorbent assay for recombinant K39 antigen in diagnosis and prognosis of Indian visceral leishmaniasis.
    Kumar R; Pai K; Pathak K; Sundar S
    Clin Diagn Lab Immunol; 2001 Nov; 8(6):1220-4. PubMed ID: 11687466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting kala-azar disease manifestations in asymptomatic patients with latent Leishmania donovani infection by detection of antibody against recombinant K39 antigen.
    Singh S; Kumari V; Singh N
    Clin Diagn Lab Immunol; 2002 May; 9(3):568-72. PubMed ID: 11986261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short report: production of recombinant kinesin-related protein of Leishmania donovani and its application in the serodiagnosis of visceral leishmaniasis.
    Takagi H; Islam MZ; Itoh M; Islam AU; Saifuddin Ekram AR; Hussain SM; Hashiguchi Y; Kimura E
    Am J Trop Med Hyg; 2007 May; 76(5):902-5. PubMed ID: 17488913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of an improved method for the recombinant k 39 enzyme-linked immunosorbent assay to detect visceral leishmaniasis disease and infection in Bangladesh.
    Kurkjian KM; Vaz LE; Haque R; Cetre-Sossah C; Akhter S; Roy S; Steurer F; Amann J; Ali M; Chowdhury R; Wagatsuma Y; Williamson J; Crawford S; Breiman RF; Maguire JH; Bern C; Secor WE
    Clin Diagn Lab Immunol; 2005 Dec; 12(12):1410-5. PubMed ID: 16339064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cloned antigen (recombinant K39) of Leishmania chagasi diagnostic for visceral leishmaniasis in human immunodeficiency virus type 1 patients and a prognostic indicator for monitoring patients undergoing drug therapy.
    Houghton RL; Petrescu M; Benson DR; Skeiky YA; Scalone A; Badaró R; Reed SG; Gradoni L
    J Infect Dis; 1998 May; 177(5):1339-44. PubMed ID: 9593022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and prognostic value of K39 recombinant antigen in Indian leishmaniasis.
    Singh S; Gilman-Sachs A; Chang KP; Reed SG
    J Parasitol; 1995 Dec; 81(6):1000-3. PubMed ID: 8544037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. rKLO8, a novel Leishmania donovani - derived recombinant immunodominant protein for sensitive detection of visceral leishmaniasis in Sudan.
    Abass E; Bollig N; Reinhard K; Camara B; Mansour D; Visekruna A; Lohoff M; Steinhoff U
    PLoS Negl Trop Dis; 2013; 7(7):e2322. PubMed ID: 23875052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. rK39 enzyme-linked immunosorbent assay for diagnosis of Leishmania donovani infection.
    Zijlstra EE; Daifalla NS; Kager PA; Khalil EA; El-Hassan AM; Reed SG; Ghalib HW
    Clin Diagn Lab Immunol; 1998 Sep; 5(5):717-20. PubMed ID: 9729541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The sensitivity and specificity of Leishmania chagasi recombinant K39 antigen in the diagnosis of American visceral leishmaniasis and in differentiating active from subclinical infection.
    Braz RF; Nascimento ET; Martins DR; Wilson ME; Pearson RD; Reed SG; Jeronimo SM
    Am J Trop Med Hyg; 2002 Oct; 67(4):344-8. PubMed ID: 12452487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid screening with a recombinant antigen (rK39) for diagnosis of visceral leishmaniasis using dipstick.
    Qu JQ; Guan LR; Shulidan I; Zuo XP; Chai JJ; Chen SB; Kawazu S; Katakura K; Matsumoto Y; Reed SG; Chang KP
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2000; 18(3):155-8. PubMed ID: 12567693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of diagnostic performance of rK28 ELISA using urine for diagnosis of visceral leishmaniasis.
    Ghosh P; Bhaskar KR; Hossain F; Khan MA; Vallur AC; Duthie MS; Hamano S; Salam MA; Huda MM; Khan MG; Coler RN; Reed SG; Mondal D
    Parasit Vectors; 2016 Jul; 9(1):383. PubMed ID: 27377266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of direct agglutination test, rk39 Test, and ELISA for the diagnosis of visceral leishmaniasis.
    Mandal J; Khurana S; Dubey ML; Bhatia P; Varma N; Malla N
    Am J Trop Med Hyg; 2008 Jul; 79(1):76-8. PubMed ID: 18606766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of enzyme-linked immunosorbent assay for diagnosis of post-kala-azar dermal leishmaniasis with crude or recombinant k39 antigen.
    Salotra P; Sreenivas G; Nasim AA; Subba Raju BV; Ramesh V
    Clin Diagn Lab Immunol; 2002 Mar; 9(2):370-3. PubMed ID: 11874880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosing visceral leishmaniasis with the recombinant K39 strip test: experience from the Sudan.
    Zijlstra EE; Nur Y; Desjeux P; Khalil EA; El-Hassan AM; Groen J
    Trop Med Int Health; 2001 Feb; 6(2):108-13. PubMed ID: 11251906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compararative evaluation of rK9, rK26 and rK39 antigens in the serodiagnosis of Indian visceral leishmaniasis.
    Mohapatra TM; Singh DP; Sen MR; Bharti K; Sundar S
    J Infect Dev Ctries; 2010 Mar; 4(2):114-7. PubMed ID: 20212344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis.
    Burns JM; Shreffler WG; Benson DR; Ghalib HW; Badaro R; Reed SG
    Proc Natl Acad Sci U S A; 1993 Jan; 90(2):775-9. PubMed ID: 8421715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leishmania infantum recombinant kinesin degenerated derived repeat (rKDDR): A novel potential antigen for serodiagnosis of visceral leishmaniasis.
    Dhom-Lemos L; Viana AG; Cunha JLR; Cardoso MS; Mendes TAO; Pinheiro GRG; Siqueira WF; Lobo FP; Teles LF; Bueno LL; Guimarães-Carvalho SF; Bartholomeu DC; Fujiwara RT
    PLoS One; 2019; 14(1):e0211719. PubMed ID: 30703138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. rK39: a cloned antigen of Leishmania chagasi that predicts active visceral leishmaniasis.
    Badaró R; Benson D; Eulálio MC; Freire M; Cunha S; Netto EM; Pedral-Sampaio D; Madureira C; Burns JM; Houghton RL; David JR; Reed SG
    J Infect Dis; 1996 Mar; 173(3):758-61. PubMed ID: 8627048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific K39 antibody response and its persistence after treatment in patients with imported leishmaniasis.
    Reiter-Owona I; Rehkaemper-Schaefer C; Arriens S; Rosenstock P; Pfarr K; Hoerauf A
    Parasitol Res; 2016 Feb; 115(2):761-9. PubMed ID: 26508007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of the recombinant K39 dipstick test and the direct agglutination test in a setting endemic for visceral leishmaniasis in Nepal.
    Bern C; Jha SN; Joshi AB; Thakur GD; Bista MB
    Am J Trop Med Hyg; 2000; 63(3-4):153-7. PubMed ID: 11388508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.